Clinical Trial Update: A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares higher-dose chemotherapy over a shorter period with lower-dose chemotherapy plus maintenance over a longer period in newly dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Snippet

Sponsor: Children's Oncology Group | Conditions: Rhabdomyosarcoma | Phase 3 | Status: NOT_YET_RECRUITING